Clinical Test Expectation – JBSNF-000088- 10MG – Human Subjects : Reduces body weight and restores glucose tolerance, both caused by diet-induced obesity (DIO)
Strength – 10MG per vial
Introduction.
JBSNF-000088 (6-Methoxynicotinamide), a analog of nicotinamide (NA), is a potent Nicotinamide N-methyltransferase (NNMT) inhibitor with IC50s of 1.8 µM for human NNMT. JBSNF-000088 inhibits NNMT activity, reduces MNA levels and drives insulin sensitization, glucose modulation and body weight reduction in models of metabolic disease. JBSNF-000088 reduces body weight and restores glucose tolerance, both caused by diet-induced obesity (DIO).
Dosing Details – Please visit this link for Dosing instructions : https://researchpeptides.co.za/dosage-instructions/




Reviews
There are no reviews yet.